Paper8816396
Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells.
Oshimi Y and 4 others. J Immunol, 1996. Cited by 169 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. Papers, record 8816396. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8816396
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apoptosis | Major topic |
| Cytotoxicity, Immunologic | Major topic |
| Killer Cells, Natural | Major topic |
| Membrane Glycoproteins | Major topic |
| fas Receptor | Major topic |
| Antibodies, Monoclonal | |
| Antibody-Dependent Cell Cytotoxicity | |
| Base Sequence | |
| Burkitt Lymphoma | |
| Calcium | |
| Fas Ligand Protein | |
| Humans | |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | |
| Leukemia-Lymphoma, Adult T-Cell | |
| Molecular Sequence Data | |
| Perforin | |
| Pore Forming Cytotoxic Proteins | |
| RNA, Messenger | |
| Recombinant Proteins | |
| Transfection | |
| Tumor Cells, Cultured |
Source PubMed
Cited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 169 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,840,992 | From local lesion to multisystem disease: integrated crosstalk among the gut microbiota, immune system, and host metabolism in endometriosis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42840992 | PubMed |
| 42,756,352 | Research progress on the role and dysregulation of NK cells in anti-tuberculosis immunity. | Front Immunol | 2026 | https://conductscience.org/library/papers/42756352 | PubMed |
| 41,618,610 | Antibody-Targeted Artificial T Cell and Natural Killer Cell Derived Vesicles for Cancer Immunotherapy. | J Extracell Vesicles | 2026 | https://conductscience.org/library/papers/41618610 | PubMed |
| 40,977,720 | Dysfunction of natural killer cells promotes immune escape and disease progression in endometriosis. | Front Immunol | 2025 | https://conductscience.org/library/papers/40977720 | PubMed |
| 40,825,006 | Cytotoxic granules and effector molecules from immune cells in tuberculosis: Mechanisms of host defense and therapeutic potential. | Virulence | 2025 | https://conductscience.org/library/papers/40825006 | PubMed |
| 40,650,051 | The Autophagy Inhibitor Bafilomycin Inhibits Antibody-Dependent Natural Killer Cell-Mediated Killing of Breast Carcinoma Cells. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40650051 | PubMed |
| 40,330,016 | FAS mediates apoptosis, inflammation, and treatment of pathogen infection. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/40330016 | PubMed |
| 35,651,603 | All About (NK Cell-Mediated) Death in Two Acts and an Unexpected Encore: Initiation, Execution and Activation of Adaptive Immunity. | Front Immunol | 2022 | https://conductscience.org/library/papers/35651603 | PubMed |
| 35,283,421 | Apigenin Increases Natural Killer Cytotoxicity to Human Hepatocellular Carcinoma Expressing HIF-1α through High Interaction of CD95/CD95L. | J Microbiol Biotechnol | 2022 | https://conductscience.org/library/papers/35283421 | PubMed |
| 34,546,587 | Single-cell transcriptome analysis reveals defective decidua stromal niche attributes to recurrent spontaneous abortion. | Cell Prolif | 2021 | https://conductscience.org/library/papers/34546587 | PubMed |
| 33,479,898 | Characterization and Activation of Fas Ligand-Producing Mouse B Cells and Their Killer Exosomes. | Methods Mol Biol | 2021 | https://conductscience.org/library/papers/33479898 | PubMed |
| 33,315,236 | Immunological basis of early clearance of Mycobacterium tuberculosis infection: the role of natural killer cells. | Clin Exp Immunol | 2021 | https://conductscience.org/library/papers/33315236 | PubMed |
| 32,365,592 | Stress Management: Death Receptor Signalling and Cross-Talks with the Unfolded Protein Response in Cancer. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32365592 | PubMed |
| 31,921,693 | Target-Dependent Expression of IL12 by synNotch Receptor-Engineered NK92 Cells Increases the Antitumor Activities of CAR-T Cells. | Front Oncol | 2019 | https://conductscience.org/library/papers/31921693 | PubMed |
| 29,642,281 | Fas Ligand localizes to intraluminal vesicles within NK cell cytolytic granules and is enriched at the immune synapse. | Immun Inflamm Dis | 2018 | https://conductscience.org/library/papers/29642281 | PubMed |
| 27,197,149 | In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments. | Cancer Res | 2016 | https://conductscience.org/library/papers/27197149 | PubMed |
| 27,163,757 | Interferon Gamma and Contact-dependent Cytotoxicity Are Each Rate Limiting for Natural Killer Cell-Mediated Antibody-dependent Chronic Rejection. | Am J Transplant | 2016 | https://conductscience.org/library/papers/27163757 | PubMed |
| 27,158,340 | Epirubicin pretreatment enhances NK cell-mediated cytotoxicity against breast cancer cells in vitro. | Am J Transl Res | 2016 | https://conductscience.org/library/papers/27158340 | PubMed |
| 26,587,033 | FAS and FAS-Ligand Promoter Polymorphisms in Hepatitis B Virus Infection. | Hepat Mon | 2015 | https://conductscience.org/library/papers/26587033 | PubMed |
| 26,500,648 | Mechanisms of Control of Mycobacterium tuberculosis by NK Cells: Role of Glutathione. | Front Immunol | 2015 | https://conductscience.org/library/papers/26500648 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FAS | 355 | PubTator's text mining | https://conductscience.org/library/genes/355 | NCBI Gene |
| FASLG | 356 | PubTator's text mining | https://conductscience.org/library/genes/356 | NCBI Gene |
| FCGR3A | 2,214 | PubTator's text mining | https://conductscience.org/library/genes/2214 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8816396
GET https://conductscience.org/api/papers/v1/8816396/cited_by?page=2